Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,704 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06641752Recruiting
Testing a new carbon monoxide test in the ER
This trial looks at a fast blood test (capillary HbCO) to measure carbon monoxide poisoning in people coming to the ER with possible CO symptoms. It could help doctors diagnose and treat CO poisoning quicker.
Angers, Loire-AtlantiqueAges 18 years+ - NCT07366099Recruiting
Special PET scan for tumor-induced osteomalacia
This trial tests a new PET/CT scan (using a tracer called Al18F-NOTA-LM3) to better find tumors causing TIO, a condition that leads to bone softening and weakness. It may help doctors diagnose and treat TIO more accurately.
Beijing, Beijing MunicipalityAges 18–80 - NCT07439458Recruiting
Exercise effects on tumor cells in breast cancer survivors
This trial tests whether different types and intensities of exercise can change tumor-related cells in survivors of triple-negative breast cancer. It may help understand how exercise could improve long-term outcomes.
Riga, Dzirciema Street 16Ages 35 years+ - NCT06622759RecruitingPhase 2
Using a collagen membrane to preserve gum bone after dental implant
This trial tests whether a special collagen material placed around a new dental implant can help prevent bone loss in the upper front gum area. It is for people needing a single implant in a specific tooth zone and may help keep the bone strong for a better cosmetic result.
Thessaloniki, ThessalonikiAges 18–75 - NCT07369739RecruitingPhase 2/Phase 3
Combination therapy for chronic active Epstein-Barr virus disease
This trial tests two drugs, golidocitinib and selinexor, given together to treat chronic active Epstein-Barr virus disease (CAEBVD). The goal is to see if this combination can help control the disease better than current options.
BeijingAges 18–70 - NCT06611891RecruitingPhase 3
PET scan study for breast cancer with hormone receptors
This study tests a special PET scan called 68Ga-DOTATOC to see if it can find certain breast cancer cells in the body. It may help doctors better understand your cancer, especially if it has spread to the liver or bones.
GrenobleAges 18–99 - NCT06697665RecruitingEarly Phase 1
LM103 vaccine with PD-1 for advanced solid tumors
This trial tests a new personalized cancer vaccine (LM103) combined with an immunotherapy drug (PD-1) for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if this combination is safe and can help shrink tumors.
China, Tianjin MunicipalityAges 18–75 - NCT06604533Recruiting
MRI-guided radiation for abdominal cancer spread
This trial tests if MRI-guided radiation can precisely target and treat cancer that has spread to a few spots in the abdomen (like the liver or lymph nodes). It's for people whose original cancer is under control and who have up to 5 small tumors in up to 2 body areas.
Darlinghurst, New South WalesAges 18 years+ - NCT06602349Recruiting
Lidocaine injection for chronic anal/perineal pain
This trial tests whether injecting a numbing medicine (lidocaine) into the painful area helps people with chronic, unexplained pain in the anal or perineal region. It is for patients who have not gotten relief from standard treatments and whose MRI shows no other cause.
Paris, Île-de-France RegionAges 18 years+ - NCT06600308Recruiting
Walking study for people with facioscapulohumeral muscular dystrophy
This study looks at how walking changes over time in people with facioscapulohumeral muscular dystrophy (FSHD). It aims to understand walking patterns to help improve future care.
DijonAges 18 years+ - NCT07734337Enrolling by invitation
Reconstruction surgery for upper body soft tissue defects
This trial tests a surgical technique using a skin flap from the back (called a TDAP flap) to repair defects in the upper body, such as after cancer surgery, injury, or scar release. It may help patients who need reconstructive surgery on the breast, shoulder, chest wall, or armpit.
Sohag, Sohag GovernorateAges 5–75 - NCT06590805Recruiting
Electroacupuncture for low milk supply after C-section
This study tests whether using tiny needles at specific points on the skin (electroacupuncture) can help increase milk supply for mothers who had a C-section. It is for healthy women between 25 and 30 years old who are partially bottle-feeding and feel their milk is low.
KafrelsheikhAges 25–30 - NCT06589258Recruiting
How CBD passes into breastmilk
This study looks at how cannabidiol (CBD) gets into breastmilk while you are breastfeeding. It helps answer whether CBD passes to your baby through milk.
OrléansAges 18 years+ - NCT07509450Recruiting
Fecal transplant study for CAR-T and stem cell transplant patients
This pilot study tests whether giving a fecal microbiota transplant before standard CAR-T therapy (for B-cell lymphoma) or reduced-intensity stem cell transplant (for AML or high-risk MDS) can improve treatment outcomes. It aims to see if restoring gut bacteria helps reduce complications.
Toronto, OntarioAges 18 years+ - NCT07660965Recruiting
Podcast breastfeeding training for mothers of preterm infants
This trial tests whether listening to a podcast about breastfeeding helps mothers of preterm babies feel more confident and successful at breastfeeding. If you are a Turkish-speaking mother of a baby born between 32 and 37 weeks, you may be eligible.
Merkez, OrduAges 18 years+ - NCT06557057Recruiting
Aromatase inhibitors and diabetes risk in breast cancer
This study looks at how aromatase inhibitors, a type of hormone therapy for breast cancer, affect blood sugar and diabetes risk. It compares women taking these drugs to those on tamoxifen or healthy women, to see if there are changes in glucose control.
Rochester, MinnesotaAges Any age - NCT06990711RecruitingPhase 1
Siltuximab for antibody-mediated rejection after lung transplant
This trial tests a drug called siltuximab to see if it can help treat a type of lung rejection called antibody-mediated rejection (AMR) in people who have had a lung transplant. You may be eligible if you are currently hospitalized for AMR and are already planning to receive standard treatments.
St Louis, MissouriAges 18 years+ - NCT06989372Enrolling by invitation
Nerve blocks for pain relief after chest surgery
This study compares two different nerve block methods to see which provides better pain control. If you qualify, you may receive one of these blocks before your chest surgery.
CairoAges 18–65 - NCT01898663RecruitingPhase 1/Phase 2
Vaccine plus immune cell therapy for adults with AML
This early-phase study tests a combined treatment—an immune “DC” vaccine plus specially trained killer immune cells—for adults with AML. The goal is to see if this approach is safe and can help control the disease.
BeijingAges 18 years+ - NCT06004336RecruitingPhase 2
Maintenance therapy after radiation for limited spread kidney cancer
This trial tests whether giving a maintenance medication (pembrolizumab) after targeted radiation helps keep kidney cancer that has spread to a few spots (5 or fewer) from growing. You would receive radiation to each spot and then be randomly assigned to receive either the medication or a placebo (inactive substance) for up to about 2 years.
Houston, TexasAges 18 years+ - NCT01717924Recruiting
Surgery vs first chemotherapy for stomach signet ring cancer
This trial compares doing surgery first versus starting chemotherapy first for people with resectable signet ring–type stomach cancer. It aims to find which approach works better to cure the cancer and prevent spread.
LilleAges 18–80 - NCT06510205Recruiting
Long-term safety of Mentor breast implants in Chinese women
This study follows women who have Mentor breast implants for 5 years to check their long-term safety. It collects information from your medical records and follow-up visits to monitor how the implants are doing.
ChengduAges 18–100 - NCT06007027Recruiting
Vaginal laser therapy for breast cancer survivors with menopause symptoms
This trial tests whether a vaginal laser treatment can help breast cancer survivors who have menopause-like symptoms such as vaginal dryness or pain during sex. It is designed for women currently on hormone-blocking therapy.
RandersAges 18–100 - NCT06509490Recruiting
CAR-T cell therapy for advanced NKG2DL-positive solid tumors
This trial tests a new type of immune cell therapy (NKG2D CAR-T cells) for people with advanced solid tumors that have not responded to standard treatments. It aims to see if these specially engineered cells can shrink tumors or slow their growth.
Beijing, Beijing MunicipalityAges 18–70
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,704 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.